MINNEAPOLIS, June 17, 2019 /PRNewswire/ — Bio-Techne today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its ExoDx Prostate IntelliScore (EPI) test, making it the first exosome-based liquid biopsy test to receive a Breakthrough Device Designation. This designation not only validates the clinical importance of Bio-Techne’s EPI test, […]
One in Two Women in the United States Will Suffer a Fracture in Her Lifetime Due to Osteoporosis(1) EVENITY is the First and Only Bone Builder With a Dual Effect That Both Increases Bone Formation and Decreases Bone Loss(2) EVENITY Rapidly Reduces Fracture Risk and Builds New Bone With 12 Months of Therapy(2) THOUSAND OAKS, […]
Healthcare’s Move from Volume to Value Fuels Startup Investment As industry leaders work to redefine value in healthcare, payers and providers are offering access to the once-impenetrable healthcare marketplace for new technologies. As large healthcare systems and payers expand their own investment portfolios, they are becoming familiar with the value that startups can drive and […]
Records Fall in Q1 As Money Flows Into Medical Alley’s Startup and Growth-Stage Companies After setting a record with their best-ever Q1 in 2018, Medical Alley startup companies didn’t just set the record again, they shattered it! For the third consecutive year, Medical Alley startup and growth-stage companies broke the previous record for money raised […]
7-Year Data from the SANTE Trial Showed Median Seizure Frequency Reduction of 75 percent in Patients with Drug-Resistant Epilepsy with Partial-Onset Seizures Receiving DBS Therapy. DUBLIN – May 1, 2018 – Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval for Medtronic’s Deep […]
